CHEMOSAT System to be Launched by Delcath

Delcath Systems, Inc. introduced that this Company has got into a first launch and working out contract for Delcath Hepatic CHEMOSAT Delivery system together with the Institute Oncologico Baselga (IOB), Group Quiron—a confidential hospital located in Barcelona, Spain. The CHEMOSAT course at the IOB will certainly be led by Javier Cortes, MD, PhD, Partner and Head of Breast Cancer and Tumor Methods. Dr. Cortes is likewise the Head of the Breast Cancer as well as the Melanoma Programs at Vall d'Hebron University Hospital in Barcelona.

By the terms of the contract, the firm will offer the IOB with logistics and clinical training help within the overall performance of chemo saturation session by using CHEMOSAT system. Courses are predicted to happen in May, and upon completion the location will come to be the very first in Spain to provide Delcath's chemo saturation system.

Statement at the announcement, Dr. Cortes, said, "Institute Oncologico Baselga is devoted to supplying state-of-the-art treatment to melanoma affected individuals in Spain. The results we have seen implies Delcath's CHEMOSAT system might be a potentially effective answer in the remedy for cancers within the liver. We are delighted to be the first organization in Spain to begin discovering the potential of the system in affected individuals with liver tumors originating from a variety of cancers."

"This entire contract by using IOB represents our first inroads into Spain, one of our main target markets," said Eamonn P. Hobbs, President and Chief executive officer of Delcath Systems. "The IOB also symbolizes our fifth center within our fourth European market, following at the centers now we have established in France, Germany and Italy. We're satisfied with the pace of our own roll out of CHEMOSAT within the EU, and expect to declare other new agreements within the coming months."